Activin A

Activin A 製品リスト

  • 属性

    Protein (8)Kits (1)

  • 製品ライブラリ

    オンライン (9)

  • Human (9)

  • タグ

    His Tag (1)Tag Free (7)- (1)

  • マーカー

    Unconjugated (8)- (1)

Activin Aバックグランド

Activin and inhibin are two closely related protein complexes that have almost directly opposite biological effects. Activin enhances FSH biosynthesis and secretion, and participates in the regulation of the menstrual cycle. Many other functions have been found to be exerted by activin, including roles in cell proliferation, differentiation, apoptosis, metabolism, homeostasis, immune response, wound repair, and endocrine function. Conversely inhibin down regulates FSH synthesis and inhibits FSH secretion.Activins are nonglycosylated homodimers or heterodimers of various β subunits (βA, βB, βC, and βE in mammals), while Inhibins are heterodimers of a unique α subunit and one of the β subunits. Activin A is a widely expressed homodimer of two βA chains. The βA subunit can also heterodimerize with a βB or βC subunit to form Activin AB and Activin AC, respectively. The 14 kDa mature human βA chain shares 100% amino acid sequence identity with bovine, feline, mouse, porcine, and rat βA.

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
BLU-782BLU-782; IPN-60130Phase 2 ClinicalBlueprint Medicines Corp, Ipsen SAMyositis Ossificans
詳細
ZilurgisertibINCB-000928; INCB-00928Phase 2 ClinicalIncyte CorpPolycythemia Vera; Renal Insufficiency; Anemia; Myelodysplastic Syndromes; Ossification, Heterotopic; Multiple Myeloma; Primary Myelofibrosis; Myositis Ossificans; Thrombocythemia, Essential
詳細
KER-047KER-047; TRND482477Phase 1 ClinicalNational Center For Advancing Translational SciencesAnemia, Iron-Deficiency; Myositis Ossificans
詳細
ItacnosertibTP-0184Phase 1 ClinicalTolero Pharmaceuticals Inc, Sumitomo DainipponSolid tumours; Anemia
詳細
BCX-9250BCX-9250Phase 1 ClinicalBiocryst Pharmaceuticals IncMyositis Ossificans
詳細
HS135HS-135Phase 1 Clinical35Pharma IncHypertension, Pulmonary; Heart Failure, Diastolic; Pulmonary Arterial Hypertension
詳細

市販薬剤に関する情報

英語名研究コード研究開発ステージ会社オリジナル製品名最初に承認をした国最初の適応症最初に承認を受けた会社承認された日付適応症臨床試験
Momelotinib DihydrochlorideCYT-387; GS-0387; GSK-3070785ApprovedGilead Sciences Inc, Cytopia Pty LtdOjjaara, OmjjaraUnited StatesPrimary Myelofibrosis; AnemiaGlaxosmithkline Llc, Glaxosmithkline Plc2023-09-15Polycythemia Vera; Anemia; Myelodysplastic Syndromes; Neoplasms; Myeloproliferative Disorders; Pancreatic Intraductal Neoplasms; Primary Myelofibrosis; Carcinoma, Pancreatic Ductal; Splenomegaly; Thrombocythemia, Essential; Carcinoma, Non-Small-Cell Lung
詳細
  • 製品リスト
  • 市販薬剤に関する情報
  • 治験薬に関する情報
お問い合わせ

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8